NN-3202

N/A

Report date: 2025/01/26 16:02:23

Base Information

Drug NameNN-3202
Drug Alias Namec-KIT antibody-drug conjugate therapy (Novelty Nobility)c-KIT antibody-drug conjugate therapy (Novelty Nobility)NN-3202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsSmall Cell Lung CarcinomaGastrointestinal Stromal TumorsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovelty Nobility Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovelty Nobility Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaGastrointestinal Stromal TumorsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A